(Q90616784)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

review article

1 reference

title

Potential Biomarkers to Improve the Prediction of Osteoporotic Fractures (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

author name string

Seung Hun Lee

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

Jung Min Koh

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

publication date

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

Endocrinology and metabolism : EnM

15 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

page(s)

55-63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 4.0 International

15 April 2020

copyright license

start time

1 January 2020

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The diagnosis of osteoporosis

1 reference

12 December 2020

Osteoblast-specific factor 2: cloning of a putative bone adhesion protein with homology with the insect protein fasciclin I

1 reference

12 December 2020

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

12 December 2020

Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study

1 reference

12 December 2020

A cDNA encoding a putative 37 kDa leucine-rich repeat (LRR) protein, p37NB, isolated from S-type neuroblastoma cell has a differential tissue distribution

1 reference

12 December 2020

Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study

1 reference

12 December 2020

Osteoporosis prevention, diagnosis, and therapy

1 reference

12 December 2020

Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the OFELY prospective study

1 reference

12 December 2020

The phospholipids sphingosine-1-phosphate and lysophosphatidic acid prevent apoptosis in osteoblastic cells via a signaling pathway involving G(i) proteins and phosphatidylinositol-3 kinase

1 reference

12 December 2020

Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction

1 reference

12 December 2020

Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates

1 reference

12 December 2020

Bone strength and its determinants

1 reference

12 December 2020

Osteoclast differentiation and activation

1 reference

12 December 2020

Biochemical markers of bone metabolism and prediction of fracture in elderly women.

1 reference

12 December 2020

Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis

1 reference

12 December 2020

A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women

1 reference

12 December 2020

Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate

1 reference

12 December 2020

Biochemical markers of bone formation reflect endosteal bone loss in elderly men--MINOS study.

1 reference

12 December 2020

Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis

1 reference

12 December 2020

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

1 reference

12 December 2020

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

1 reference

12 December 2020

Canonical WNT Signaling Promotes Osteogenesis by Directly StimulatingRunx2Gene Expression

1 reference

12 December 2020

Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss

1 reference

12 December 2020

Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis

1 reference

12 December 2020

Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling

1 reference

12 December 2020

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

1 reference

12 December 2020

Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1.

1 reference

12 December 2020

Cathepsin K predicts femoral neck bone mineral density change in nonosteoporotic peri- and early postmenopausal women

1 reference

12 December 2020

S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake

1 reference

12 December 2020

Circulating RANKL is inversely related to RANKL mRNA levels in bone in osteoarthritic males.

1 reference

12 December 2020

FRAX and the assessment of fracture probability in men and women from the UK

1 reference

12 December 2020

Circulating profiles of osteoprotegerin and soluble receptor activator of nuclear factor kappaB ligand in post-menopausal women

1 reference

12 December 2020

Sphingosine-1-phosphate acts as a developmental stage specific inhibitor of platelet-derived growth factor-induced chemotaxis of osteoblasts.

1 reference

12 December 2020

Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women.

1 reference

12 December 2020

Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis

1 reference

12 December 2020

Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclast differentiation

1 reference

12 December 2020

Denosumab for prevention of fractures in postmenopausal women with osteoporosis

1 reference

12 December 2020

The matricellular protein periostin is required for sost inhibition and the anabolic response to mechanical loading and physical activity

1 reference

12 December 2020

Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool

1 reference

12 December 2020

Optimal Combinations of Diagnostic Tests Based on AUC.

1 reference

12 December 2020

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

1 reference

12 December 2020

Serum fibroblast growth factor-23 (FGF-23) and fracture risk in elderly men

1 reference

12 December 2020

Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo

1 reference

12 December 2020

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

1 reference

12 December 2020

Determinants of serum sclerostin in healthy pre- and postmenopausal women

1 reference

12 December 2020

Relationship between serum RANKL and RANKL in bone

1 reference

12 December 2020

Evidence for osteocyte regulation of bone homeostasis through RANKL expression

1 reference

12 December 2020

Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway

1 reference

12 December 2020

The multiple facets of periostin in bone metabolism

1 reference

12 December 2020

Serum sclerostin and risk of hip fracture in older Caucasian women

1 reference

12 December 2020

Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.

1 reference

12 December 2020

Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans

1 reference

12 December 2020

High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.

1 reference

12 December 2020

Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women

1 reference

12 December 2020

Regulation of beta catenin signaling and parathyroid hormone anabolic effects in bone by the matricellular protein periostin

1 reference

12 December 2020

Lower fracture risk in older men with higher sclerostin concentration: a prospective analysis from the MINOS study.

1 reference

12 December 2020

Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation

1 reference

12 December 2020

Multiparameter analysis of serum levels of C-telopeptide crosslaps, bone-specific alkaline phosphatase, cathepsin K, osteoprotegerin and receptor activator of nuclear factor κB ligand in the diagnosis of osteoporosis

1 reference

12 December 2020

Romosozumab in postmenopausal women with low bone mineral density.

1 reference

12 December 2020

A meta-analysis of reference markers of bone turnover for prediction of fracture

1 reference

12 December 2020

Serum periostin is associated with fracture risk in postmenopausal women: a 7-year prospective analysis of the OFELY study.

1 reference

12 December 2020

Update on denosumab treatment in postmenopausal women with osteoporosis

1 reference

12 December 2020

The macrophage migration inhibitory factor protein superfamily in obesity and wound repair

1 reference

12 December 2020

The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient

1 reference

12 December 2020

Plasma periostin associates significantly with non-vertebral but not vertebral fractures in postmenopausal women: Clinical evidence for the different effects of periostin depending on the skeletal site

1 reference

12 December 2020

Emerging Therapies for Osteoporosis

1 reference

12 December 2020

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone

1 reference

12 December 2020

The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study

1 reference

12 December 2020

Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women

1 reference

12 December 2020

Association of bone turnover markers with volumetric bone loss, periosteal apposition, and fracture risk in older men and women: the AGES-Reykjavik longitudinal study

1 reference

12 December 2020

Low Plasma Level of Leucine-Rich Repeat-Containing 17 (LRRc17) Is an Independent and Additive Risk Factor for Osteoporotic Fractures in Postmenopausal Women.

1 reference

12 December 2020

Clinical usefulness of bone turnover marker concentrations in osteoporosis.

1 reference

12 December 2020

The Association of Higher Plasma Macrophage Migration Inhibitory Factor Levels with Lower Bone Mineral Density and Higher Bone Turnover Rate in Postmenopausal Women.

1 reference

12 December 2020

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

1 reference

12 December 2020

Association of circulating dipeptidyl-peptidase 4 levels with osteoporotic fracture in postmenopausal women.

1 reference

12 December 2020

The Utility of Biomarkers in Osteoporosis Management.

1 reference

12 December 2020

Osteoclast-secreted SLIT3 coordinates bone resorption and formation

1 reference

12 December 2020

Clinical Utility of Biochemical Marker of Bone Turnover: Fracture Risk Prediction and Bone Healing.

1 reference

12 December 2020

High Plasma Sphingosine 1-phosphate Levels Predict Osteoporotic Fractures in Postmenopausal Women: The Center of Excellence for Osteoporosis Research Study.

1 reference

12 December 2020

Bone turnover: Biology and assessment tools

1 reference

12 December 2020

One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study

1 reference

12 December 2020

Coupling factors involved in preserving bone balance

1 reference

12 December 2020

1 reference

12 December 2020

Clinical Application of Bone Turnover Markers in Osteoporosis in Korea

1 reference

12 December 2020

Disability Weights for Osteoporosis and Osteoporotic Fractures in South Korea.

1 reference

12 December 2020

Identifiers

DOI

10.3803/ENM.2020.35.1.55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32207264%20AND%20SRC:MED&resulttype=core&format=json

15 April 2020

PubMed publication ID

32207264

1 reference